Blueprint Medicines Corp Capital Reinvestment Ratio
Blueprint Medicines Corp capital reinvestment ratio. Blueprint Medicines Corp (BPMC) has a Capital Reinvestment Ratio of 0.00x as of September 2020, meaning it reinvests 0% of its operating cash flow ($622.33 Million) in capital expenditures ($6.00K). Check BPMC cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Blueprint Medicines Corp (2020–2020)
Capital reinvestment ratio of Blueprint Medicines Corp from 2020 to 2020. This chart tracks Blueprint Medicines Corp's Capital Reinvestment Ratio across 1 annual periods. Also explore Blueprint Medicines Corp (BPMC) net asset momentum to track the company's year-over-year net asset growth rate.
Blueprint Medicines Corp Capital Reinvestment Ratio by Year (2020–2020)
Blueprint Medicines Corp capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see BPMC cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.01x | $387.04 Million | $3.16 Million | — |